Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
2020
2,255 citations
Journal Article
Field-Weighted Citation Impact:
103.56
·
University of Alabama at Birmingham
Enkhtsetseg Purev
·
University of Colorado Denver
David G. Maloney
·
Fred Hutch Cancer Center
Charalambos Andreadis
·
University of California, San Francisco
Alison R. Sehgal
·
University of Pittsburgh Medical Center
Scott R. Solomon
·
Northside Hospital
Nilanjan Ghosh
·
Levine Cancer Institute
Tina Albertson
·
Bristol-Myers Squibb (United States)
Jacob Garcia
·
Bristol-Myers Squibb (United States)
Ana Kostić
·
Bristol-Myers Squibb (United States)
Mary Mallaney
·
Bristol-Myers Squibb (United States)
K. OGASAWARA
·
Bristol-Myers Squibb (United States)
Kathryn J. Newhall
·
Bristol-Myers Squibb (United States)
Yeonhee Kim
·
Bristol-Myers Squibb (United States)
D. Li
·
Bristol-Myers Squibb (United States)
Tanya Siddiqi
·
City Of Hope National Medical Center
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study | Researchclopedia